A61K31/485 - page 11 - CPC Classification Index

#3001

20130123295

2013-05-16

TREATMENT OF NEUROPATHIC PAIN WITH N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONISTS

#3002

20130123293

2013-05-16

Opioid-containing oral pharmaceutical compositions and methods

#3003

20130122101

2013-05-16

Abuse resistant drug formulation

#3004

20130122098

2013-05-16

Method and composition to improve absorption of therapeutic agents

#3005

20130122087

2013-05-16

Abuse resistant drug formulation

#3006

20130109762

2013-05-02

Silk particles for controlled and sustained delivery of compounds

#3007

20130109674

2013-05-02

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE, AND VASCULAR CONDITIONS

#3008

20130101660

2013-04-25

TRANSDERMAL DELIVERY PATCH

#3009

20130095145

2013-04-18

Preparation for Transnasal Application

#3010

20130090350

2013-04-11

Combination analgesic employing opioid agonist and neutral antagonist

#3011

20130084333

2013-04-04

Abuse resistant oral dosage forms

#3012

20130084311

2013-04-04

Lingual vestibular dosage-form and delivery system for transmucosal administration of pharmaceutical agents

#3013

20130072517

2013-03-21

PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

#3014

20130072516

2013-03-21

METHOD OF ALCOHOL CESSATION AND TREATMENT

#3015

20130072515

2013-03-21

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

#3016

20130072514

2013-03-21

Sustained-Release Opioid Formulations and Methods of Use

#3017

20130071477

2013-03-21

NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE

#3018

20130071476

2013-03-21

Rapid Melt Controlled Release Taste-Masked Compositions

#3019

20130065832

2013-03-14

Composition and methods for reducing opioid-induced pruritus

#3020

20130064890

2013-03-14

PHARMACEUTICAL FORMULATION BASED ON IBUPROFEN AND CODEINE HAVING IMPROVED STABILITY

#3021

20130059876

2013-03-07

LIQUID NASAL SPRAY CONTAINING LOW-DOSE NALTREXONE

#3022

20130059010

2013-03-07

ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM

#3023

20130059007

2013-03-07

Modified release formulations containing drug-ion exchange resin complexes

#3024

20130053411

2013-02-28

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION

#3025

20130053368

2013-02-28

Methods for treatment of Parkinson's disease

#3026

20130045960

2013-02-21

Abuse-deterrent pharmaceutical compositions of opiods and other drugs

#3027

20130045268

2013-02-21

Abuse-resistant mucoadhesive devices for delivery of buprenorphine

#3028

20130045165

2013-02-21

4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators

#3029

20130035510

2013-02-07

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

#3030

20130034503

2013-02-07

Preventing or reducing drug abuse and overdose events

#3031

20130030056

2013-01-31

Methods of delivering pharmaceutical agents

#3032

20130028972

2013-01-31

Tamper-resistant tablet providing immediate drug release

#3033

20130023553

2013-01-24

PEGYLATED OPIOIDS WITH LOW POTENTIAL FOR ABUSE AND SIDE EFFECTS

#3034

20130022689

2013-01-24

Use of amisulpride as an anti-emetic

#3035

20130022688

2013-01-24

Use of amisulpride as an anti-emetic

#3036

20130022646

2013-01-24

Controlled Release Formulations of Opioids

#3037

20130022593

2013-01-24

METHODS OF DIAGNOSING ENDOMETRIOSIS

#3038

20130017255

2013-01-17

Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent

#3039

20130012533

2013-01-10

CONTROLLED RELEASE OXYCODONE COMPOSITIONS

#3040

20130012483

2013-01-10

NOVEL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEURODEGENERATIVE OR NEUROVASCULAR DISEASES

#3041

20130011929

2013-01-10

Peripheral opioid receptor antagonists and uses thereof

#3042

20130011543

2013-01-10

CONTROLLED RELEASE OXYCODONE COMPOSITIONS

#3043

20130011479

2013-01-10

DOUBLE-LAYER PHARMACEUTICAL FORMULATIONS CONTAINING OPIOID AGONISTS AND ANTAGONISTS

#3044

20130005977

2013-01-03

Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone

#3045

20130005821

2013-01-03

Intravenous administration of tramadol

#3046

20130005755

2013-01-03

Peripherally acting opioid compounds

#3047

20120328602

2012-12-27

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH CERAMIDE BIOSYNTHESIS

#3048

20120321717

2012-12-20

DEVICES AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING DOSING EFFICIENCY

#3049

20120321713

2012-12-20

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#3050

20120321674

2012-12-20

Technology for Preventing Abuse of Solid Dosage Forms

#3051

20120316191

2012-12-13

Peripheral opioid receptor antagonists and uses thereof

#3052

20120316190

2012-12-13

Modulation of Cell Barrier Dysfunction

#3053

20120316189

2012-12-13

METHODS AND COMPOSITIONS FOR REDUCING THE RISK ASSOCIATED WITH THE ADMINISTRATION OF OPIOID ANALGESICS IN PATIENTS DIAGNOSED OR UNDIAGNOSED RESPIRATORY ILLNESS

#3054

20120316108

2012-12-13

Phospholipid depot

#3055

20120315331

2012-12-13

Pharmaceutical composition for the treatment of acute disorders

#3056

20120315330

2012-12-13

Pharmaceutical composition for the treatment of acute disorders

#3057

20120309779

2012-12-06

Methods and compositions comprising sequential administration opioid receptor agonists

#3058

20120308654

2012-12-06

ABUSE-PROOFED DOSAGE FORM

#3059

20120308614

2012-12-06

COMPOSITION FOR THE CONTROLLED RELEASE OF BUPRENORPHINE

#3060

20120308589

2012-12-06

Sinomenine derivatives, synthetic methods and uses thereof

#3061

20120302942

2012-11-29

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

#3062

20120302594

2012-11-29

Quaternary opioid carboxamides

#3063

20120302591

2012-11-29

Methods of using 8-carboxamido-2,6-methano-3-benzazocines

#3064

20120302590

2012-11-29

METHODS AND COMPOSITIONS TO PREVENT ADDICTION

#3065

20120299223

2012-11-29

DRUG LOADED FIBERS

#3066

20120295834

2012-11-22

Opioid prodrugs with heterocyclic linkers

#3067

20120294797

2012-11-22

Anti-CGRP compositions and use thereof

#3068

20120289548

2012-11-15

Oligomer-opioid agonist conjugates

#3069

20120289508

2012-11-15

Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof

#3070

20120288567

2012-11-15

Opioid agonist formulations with releasable and sequestered antagonist

#3071

20120288565

2012-11-15

Tamper-resistant oral opioid agonist formulations

#3072

20120283283

2012-11-08

METHODS FOR DETECTING ENHANCED RISK OF OPIOID-INDUCED HYPOXIA IN A PATIENT

#3073

20120282335

2012-11-08

RAPIDLY DISPERSING GRANULES, ORALLY DISINTEGRATING TABLETS AND METHODS

#3074

20120282255

2012-11-08

METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCE

#3075

20120277695

2012-11-01

TRANSDERMAL DELIVERY PATCH

#3076

20120277260

2012-11-01

USE OF METHYLNALTREXONE AND RELATED COMPOUNDS TO TREAT CONSTIPATION IN CHRONIC OPIOID USERS

#3077

20120270895

2012-10-25

Intranasal Opioid Compositions

#3078

20120270894

2012-10-25

Controlled release of phenolic opioids

#3079

20120270860

2012-10-25

METHODS FOR TREATING OR PREVENTING ALCOHOL-RELATED DISORDERS OR CRAVING-RELATED DISORDERS

#3080

20120270848

2012-10-25

Novel Compositions and Therapeutic Methods Using Same

#3081

20120270783

2012-10-25

Rapid opioid detoxification

#3082

20120269772

2012-10-25

Lipid depot formulations

#3083

20120264775

2012-10-18

Oligomer-opioid agonist conjugates

#3084

20120264742

2012-10-18

Pharmaceutical composition for external use

#3085

20120263788

2012-10-18

Controlled release hydrocodone formulations

#3086

20120258981

2012-10-11

Process for the synthesis of quaternary amine compounds

#3087

20120258161

2012-10-11

Implantable polymeric device for sustained release of dopamine agonist

#3088

20120252833

2012-10-04

Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug

#3089

20120252832

2012-10-04

ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM

#3090

20120252831

2012-10-04

COMPOSITIONS OF OPIOID ANTAGONISTS AND METHODS FOR TREATING SCLERODERMA THEREWITH

#3091

20120252824

2012-10-04

Drug Combinations and Uses in Treating a Coughing Condition

#3092

20120252794

2012-10-04

ANALGESIC COMBINATION OF OPIOID ANALGESIC AND CYCLOOXYGENASE-2 INHIBITOR

#3093

20120251637

2012-10-04

Abuse-proofed dosage form

#3094

20120251590

2012-10-04

CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

#3095

20120245193

2012-09-27

PERIPHERIALLY ACTING μ OPIOID ANTAGONISTS

#3096

20120237603

2012-09-20

ABUSE-RESISTANT OPIOID DOSAGE FORM

#3097

20120237596

2012-09-20

NUTRIENT DELIVERY DRUG COMPOSITION

#3098

20120237570

2012-09-20

Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications

#3099

20120231092

2012-09-13

Combination Therapy for Bipolar Disorder

#3100

20120231075

2012-09-13

ABUSE-RESISTANT OPIOID DOSAGE FORM

#3101

20120231061

2012-09-13

Long term drug delivery devices with polyurethane-based polymers and their manufacture

#3102

20120230916

2012-09-13

Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof

#3103

20120225901

2012-09-06

DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE

#3104

20120225893

2012-09-06

COMBINATION OF AN ANTIPSYCHOTIC AND AN ANTI-INFLAMMATORY AGENT

#3105

20120225122

2012-09-06

Abuse-Resistant Formulations

#3106

20120217184

2012-08-30

Medicament delivery device for administration of opioid antagonists including formulations for naloxone

#3107

20120208835

2012-08-16

Method and dosage regimens for eliminating a chemical substance in blood

#3108

20120208766

2012-08-16

TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING

#3109

20120207831

2012-08-16

Coated solid dosage forms

#3110

20120207789

2012-08-16

TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING

#3111

20120202780

2012-08-09

CARRIER COMPOSITION

#3112

20120202738

2012-08-09

Therapy for enteric infections

#3113

20120201895

2012-08-09

Pharmaceutical compositions for the deterrence and/or prevention of abuse

#3114

20120201888

2012-08-09

Pharmaceutical compositions

#3115

20120201887

2012-08-09

Pharmaceutical formulation

#3116

20120201761

2012-08-09

Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agent

#3117

20120195955

2012-08-02

Sublingual films

#3118

20120190702

2012-07-26

USE OF METHYLNALTREXONE AND RELATED COMPOUNDS TO TREAT CONSTIPATION IN CHRONIC OPIOID USERS

#3119

20120189705

2012-07-26

Pharmaceutical Compositions

#3120

20120184581

2012-07-19

Oligomer-opioid agonist conjugates

#3121

20120184536

2012-07-19

COMPOSITIONS COMPRISING SPECIFIC UGT INHIBITORS AND METHODS OF USE THEREOF

#3122

20120183629

2012-07-19

LOW VISCOSITY LIQUID POLYMERIC DELIVERY SYSTEM

#3123

20120183612

2012-07-19

Matrix for sustained, invariant and independent release of active compounds

#3124

20120178772

2012-07-12

Compositions comprising enzyme-cleavable oxycodone prodrug

#3125

20120178771

2012-07-12

Oral Pharmaceutical Compositions of Buprenorphine and Method of Use

#3126

20120172454

2012-07-05

Biodegradable drug delivery compositions

#3127

20120172388

2012-07-05

Enhancement of Impaired Motor and Mental Functions, Using Dextromethorphan and Oxidase Enzyme Inhibitor

#3128

20120172387

2012-07-05

OPIOIDS FOR THE TREATMENT OF THE RESTLESS LEG SYNDROME

#3129

20120165363

2012-06-28

Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders

#3130

20120165361

2012-06-28

DRUG COATING PROVIDING HIGH DRUG LOADING AND METHODS FOR PROVIDING THE SAME

#3131

20120165359

2012-06-28

Opioid agonist/antagonist combinations

#3132

20120165358

2012-06-28

CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

#3133

20120164228

2012-06-28

Pharmaceutical formulations to prevent the misuse of medicinal drugs

#3134

20120164220

2012-06-28

Encased tamper resistant controlled release dosage forms

#3135

20120164209

2012-06-28

Abuse resistant oral opioid formulations

#3136

20120164207

2012-06-28

Degradable networks for sustained release and controlled release depot drug delivery applications

#3137

20120164191

2012-06-28

TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE

#3138

20120164139

2012-06-28

Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders

#3139

20120157937

2012-06-21

Transdermal rivastigmine therapeutic system

#3140

20120157467

2012-06-21

COMPOSITION AND USE FOR PHOSPHODIESTERASE INHIBITORS

#3141

20120156301

2012-06-21

Methods and compositions for treating and preventing symptoms of hormonal variations

#3142

20120156277

2012-06-21

Abuse resistant forms of immediate release oxycodone, method of use and method of making

#3143

20120149724

2012-06-14

MODULATING ENDOGENOUS BETA-ENDORPHIN LEVELS

#3144

20120148521

2012-06-14

Methods and compositions for controlled release of drugs

#3145

20120142720

2012-06-07

Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof

#3146

20120142719

2012-06-07

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof

#3147

20120142615

2012-06-07

Methods related to the treatment of neurodegenerative and inflammatory conditions

#3148

20120141583

2012-06-07

ALCOHOL RESISTANT DOSAGE FORMS

#3149

20120136022

2012-05-31

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#3150

20120136021

2012-05-31

OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM

#3151

20120136020

2012-05-31

TREATMENT OF EFFECT OF CHEMICALS WITH THEIR ULTRADILUTE STEREOISOMERS

#3152

20120135075

2012-05-31

Tamper resistant dosage form comprising a matrix and melt-extruded particulates comprising a drug

#3153

20120135073

2012-05-31

Oral drug delivery system

#3154

20120135072

2012-05-31

Oral drug delivery system

#3155

20120135071

2012-05-31

Abuse-proofed dosage form

#3156

20120129879

2012-05-24

Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers

#3157

20120129415

2012-05-24

Destructive Disposal of Medical Active Ingredients in Transdermal Therapeutic Systems

#3158

20120121730

2012-05-17

PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS FOR TREATING RESPIRATORY DISEASE AND ASSOCIATED PHLEGM

#3159

20120121667

2012-05-17

Pharmaceutical Composition

#3160

20120115849

2012-05-10

Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors

#3161

20120114752

2012-05-10

Stable tablet containing 4,5-epoxymorphinan derivative

#3162

20120114670

2012-05-10

METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS

#3163

20120114599

2012-05-10

Opioid and opioid-like compounds and uses thereof

#3164

20120108622

2012-05-03

Pharmaceutical formulation containing gelling agent

#3165

20120108621

2012-05-03

PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE

#3166

20120107250

2012-05-03

Abuse-proofed dosage form

#3167

20120101118

2012-04-26

TAMPER RESISTANT DOSAGE FORMS

#3168

20120093889

2012-04-19

Layered pharmaceutical formulations

#3169

20120088796

2012-04-12

Compounds that inhibit (block) bitter taste in composition and use thereof

#3170

20120088787

2012-04-12

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

#3171

20120088786

2012-04-12

Immediate release pharmaceutical compositions comprising oxycodone and naloxone

#3172

20120088745

2012-04-12

CHEMICALLY MODIFIED SMALL MOLECULES

#3173

20120088744

2012-04-12

COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS

#3174

20120087982

2012-04-12

Extended release opioid abuse deterrent compositions and methods of making same

#3175

20120083506

2012-04-05

REDUCTION OF OPIOID BLOOD FLUCTUATIONS

#3176

20120083505

2012-04-05

Use of opioid receptor antagonists for acute treatment of paraphilic arousal states

#3177

20120083487

2012-04-05

COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY

#3178

20120083485

2012-04-05

NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION

#3179

20120082718

2012-04-05

Morphine Formulations

#3180

20120077800

2012-03-29

Methods for treating antipsychotic-induced weight gain

#3181

20120070495

2012-03-22

Oral formulations and lipophilic salts of methylnaltrexone

#3182

20120065221

2012-03-15

Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use

#3183

20120064152

2012-03-15

Analgesic and Anti-Inflammatory Compositions Comprising Domperidone and Methods of Using Same

#3184

20120059167

2012-03-08

Processes for preparing morphinan-6-one products with low levels of alpha beta-unsaturated compounds

#3185

20120059025

2012-03-08

DRY POWDER COMPOUND FORMULATIONS AND USES THEREOF

#3186

20120059024

2012-03-08

DRUG ABUSE DETERRENT, METHODS AND COMPOSITIONS

#3187

20120058951

2012-03-08

NEUROTENSIN RECEPTOR AGONISTS AND OPIOID RECEPTOR AGONISTS

#3188

20120053169

2012-03-01

COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY

#3189

20120041014

2012-02-16

Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia

#3190

20120041005

2012-02-16

Use of alkanoyl L-carnitine for the treatment of erectile dysfunction

#3191

20120040940

2012-02-16

Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders

#3192

20120040009

2012-02-16

PARTICULATE PHARMACEUTICAL COMPOSITION WITH AN OPIOID AND AN OPIOID ANTAGONIST

#3193

20120039962

2012-02-16

Pharmaceutical Compositions

#3194

20120034306

2012-02-09

POLYMERIC DRUG DELIVERY SYSTEMS AND PROCESSES FOR PRODUCING SUCH SYSTEMS

#3195

20120034293

2012-02-09

TRANSDERMAL DELIVERY OF CANNABINOIDS

#3196

20120029008

2012-02-02

Crystalline and amorphous forms of nalbuphine hydrochloride

#3197

20120029007

2012-02-02

MORPHINAN COMPOUNDS

#3198

20120028960

2012-02-02

Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder

#3199

20120022093

2012-01-26

Crystalline forms of oxymorphone hydrochloride

#3200

20120018333

2012-01-26

Reducing Side Effects of Tramadol

#3201

20120015031

2012-01-19

NOVEL GASTRO-RETENTIVE DOSAGE FORMS

#3202

20120015030

2012-01-19

Modified release formulations containing drug-ion exchange resin complexes

#3203

20120010232

2012-01-12

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

#3204

20120010231

2012-01-12

Dihydroetorphines and Their Preparation

#3205

20120010157

2012-01-12

Method of stimulating the motility of the gastrointestinal system using ipamorelin

#3206

20120009261

2012-01-12

NOVEL GASTRO-RETENTIVE DOSAGE FORMS

#3207

20120003290

2012-01-05

Method for reducing pain

#3208

20110318392

2011-12-29

Drug coating providing high drug loading and methods for providing the same

#3209

20110306627

2011-12-15

Morphinan compounds

#3210

20110300217

2011-12-08

HYDROMORPHONE THERAPY

#3211

20110294843

2011-12-01

ADMINISTRATION SCHEME OF POLAR OPIOID METABOLITES FOR POST-OPERATIVE PAIN MANAGEMENT

#3212

20110293716

2011-12-01

Pharmaceutical formulation containing ibuprofen and codeine

#3213

20110288114

2011-11-24

COMPOSITIONS FOR THE TREATMENT OF FIBROTIC DISEASES OR CONDITIONS

#3214

20110288113

2011-11-24

METHOD TO REDUCE OR ELMINATE THE USE BY A PATIENT OF A TOLERANCE-INDUCING PHARAMACOLOGICAL AGENT

#3215

20110288112

2011-11-24

Method of Providing Sustained Analgesia With Buprenorphine

#3216

20110288101

2011-11-24

SURGICAL COMPOSITIONS CONTAINING SIGMA-RECEPTOR AGONISTS

#3217

20110287101

2011-11-24

Rapid release mini-tablets provide analgesia in laboratory animals

#3218

20110287095

2011-11-24

Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans

#3219

20110287093

2011-11-24

ORAL DOSAGE FORMS WITH THERAPEUTICALLY ACTIVE AGENTS IN CONTROLLED RELEASE CORES AND IMMEDIATE RELEASE GELATIN CAPSULE COATS

#3220

20110281905

2011-11-17

ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR

#3221

20110281904

2011-11-17

Use of dextromethorphan in treating addictive behavior or bipolar disorder

#3222

20110281886

2011-11-17

Pharmaceutical compositions with attenuated release of phenolic opioids

#3223

20110281855

2011-11-17

And potent tapentadol dosage forms

#3224

20110280909

2011-11-17

METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE

#3225

20110275658

2011-11-10

Opioid-containing oral pharmaceutical compositions and methods

#3226

20110275616

2011-11-10

Combination Analgesic Employing Opioid and Neutral Antagonist

#3227

20110274771

2011-11-10

Prenatal Syptomatic Kit

#3228

20110270011

2011-11-03

Use of opioids or opioid mimetics for the treatment of resistant cancer patients

#3229

20110263631

2011-10-27

COMBINATION OF A SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR AND AN OPIOID AGONIST FOR THE TREATMENT OF PAIN

#3230

20110263545

2011-10-27

HEPATOPROTECTANT ACETAMINOPHEN MUTUAL PRODRUGS

#3231

20110262539

2011-10-27

Pharmaceutical compositions for treating or preventing pain

#3232

20110262532

2011-10-27

Controlled release hydrocodone formulations

#3233

20110262522

2011-10-27

Transmucosal delivery devices with enhanced uptake

#3234

20110262360

2011-10-27

Compositions Comprising Enzyme-Cleavable Phenol-Modified Opioid Prodrugs and Inhibitors Thereof

#3235

20110262359

2011-10-27

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS OF ACTIVE AGENTS AND INHIBITORS THEREOF

#3236

20110262355

2011-10-27

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE OPIOID PRODRUGS AND INHIBITORS THEREOF

#3237

20110257214

2011-10-20

Morphinan compounds

#3238

20110256226

2011-10-20

Opioid agonist formulations with releasable and sequestered antagonist

#3239

20110256070

2011-10-20

Pharmaceutical compositions and methods for administering the same

#3240

20110251229

2011-10-13

(+)-OPIOIDS AND METHODS OF USE

#3241

20110251227

2011-10-13

Analgesic agents

#3242

20110250278

2011-10-13

PARTICLES CONTAINING AN OPIOID RECEPTOR ANTAGONIST AND METHODS OF USE

#3243

20110245287

2011-10-06

Hybrid opioid compounds and compositions

#3244

20110245278

2011-10-06

Compositions of opioid antagonists and methods for treating conditions caused by the varicella-zoster virus therewith

#3245

20110245208

2011-10-06

Compositions and methods for the treatment of somatosensory disorders

#3246

20110244022

2011-10-06

TRANSDERMAL DELIVERY PATCH

#3247

20110243889

2011-10-06

Opioid and opioid-like compounds and uses thereof

#3248

20110240022

2011-10-06

AEROSOL FORMING DEVICE FOR USE IN INHALATION THERAPY

#3249

20110240013

2011-10-06

METHOD OF FORMING AN AEROSOL FOR INHALATION DELIVERY

#3250

20110237616

2011-09-29

PHEHYLEPHRINE FORMULATIONS WITH IMPROVEDS STABILITY

#3251

20110237615

2011-09-29

Narcotic drug formulations with decreased abuse potential

#3252

20110237614

2011-09-29

Pegylated Opioids with Low Potential for Abuse

#3253

20110237563

2011-09-29

FAST DISSOLVING DRUG DELIVERY SYSTEMS

#3254

20110230816

2011-09-22

Gels for Transdermal Delivery

#3255

20110230514

2011-09-22

Morphinan compounds

#3256

20110230512

2011-09-22

Pharmaceutical composition

#3257

20110230511

2011-09-22

Carboxamide bioisosteres of opiates

#3258

20110230510

2011-09-22

Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent

#3259

20110229526

2011-09-22

FORMULATIONS OF NONOPIOID AND CONFINED OPIOID ANALGESICS

#3260

20110224910

2011-09-15

METHODS OF NORMALIZING MEASURED DRUG CONCENTRATIONS AND TESTING FOR NON-COMPLIANCE WITH A DRUG TREATMENT REGIMEN

#3261

20110224179

2011-09-15

Medicament and method of diagnosis for treating subclinical Cushing's syndrome

#3262

20110224147

2011-09-15

METHODS AND COMPOSITIONS

#3263

20110218213

2011-09-08

Methods and Compositions for Treating or Preventing Symptoms of Hormonal Variations

#3264

20110218209

2011-09-08

NUTRIENT DELIEVRY DRUG COMPOSITION

#3265

20110217278

2011-09-08

Medication and treatment for disease

#3266

20110212987

2011-09-01

METHOD OF REDUCING CNS AND GASTROINTESTINAL SIDE AFFECTS ASSOCIATED WITH LONG-TERM DEXTROMETHORPHAN/LOW-DOSE QUINIDINE COMBINATION THERAPY

#3267

20110212985

2011-09-01

Naltrexone Long Acting Formulations and Methods of Use

#3268

20110208161

2011-08-25

INTRACOCHLEAR DRUG DELIVERY TO THE CENTRAL NERVOUS SYSTEM

#3269

20110207937

2011-08-25

Compounds that inhibit (block) bitter taste in composition and methods of making same

#3270

20110207763

2011-08-25

8-carboxamido-2,6-methano-3-benzazocines

#3271

20110207762

2011-08-25

OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM 14-HYDROXYCODEINONE

#3272

20110207761

2011-08-25

Diversion- and/or abuse-resistant compositions and methods for making the same

#3273

20110206782

2011-08-25

PIPERIDINE MODULATORS OF DOPAMINE RECEPTOR

#3274

20110206780

2011-08-25

MORPHINAN MODULATORS OF NMDA RECEPTORS, SIGMA1 RECEPTORS, SIGMA2 RECEPTORS, AND/OR A3B4 NICOTINIC RECEPTORS

#3275

20110201586

2011-08-18

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM

#3276

20110200681

2011-08-18

Abuse Resistant Drug Formulation

#3277

20110200675

2011-08-18

Drug delivery vehicles, methods of manufacture, and methods of use thereof

#3278

20110195989

2011-08-11

Controlled Release Formulations of Opioids

#3279

20110195988

2011-08-11

Pharmaceutical Composition

#3280

20110195042

2011-08-11

Compositions, Methods and Kits Useful for Treating a Respiratory Symptom

#3281

20110190688

2011-08-04

Permeant delivery system and methods for use thereof

#3282

20110190267

2011-08-04

PRODRUGS OF OPIOIDS AND USES THEREOF

#3283

20110190192

2011-08-04

METHODS FOR TREATING ERECTILE DYSFUNCTION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES

#3284

20110189259

2011-08-04

MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE

#3285

20110184376

2011-07-28

Long term drug delivery devices with polyurethane-based polymers and their manufacture

#3286

20110184008

2011-07-28

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

#3287

20110184007

2011-07-28

Pharmaceutical compositions configured to deter dosage form splitting

#3288

20110177133

2011-07-21

USE OF OPIOID ANTAGONISTS FOR TREATING URINARY RETENTION

#3289

20110172260

2011-07-14

Methods of providing weight loss therapy in patients with major depression

#3290

20110172259

2011-07-14

DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE

#3291

20110172196

2011-07-14

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM

#3292

20110171631

2011-07-14

Methods of diagnosing endometriosis

#3293

20110171241

2011-07-14

Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies

#3294

20110166171

2011-07-07

SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

#3295

20110165248

2011-07-07

PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(E-CAPROLACTONE)

#3296

20110165242

2011-07-07

IN SITU GELLING DRUG DELIVERY SYSTEM

#3297

20110165232

2011-07-07

Use of Opioid Antagonists for the Preparation of a Medicament in the Treatment of Retinal Degenerative Diseases

#3298

20110160239

2011-06-30

ORAL ADMINISTRATION OF PERIPHERALLY-ACTING OPIOID ANTAGONISTS

#3299

20110159100

2011-06-30

Formulations and methods for the controlled release of active drug substances

#3300

20110159090

2011-06-30

Abuse resistant drugs, method of use and method of making